Skip to main content
WeightCited

Garcinia Cambogia ： Obesity

C

Meta-analysis of 12 RCTs found small weight loss of 0.88 kg. However, the landmark JAMA trial (n=135) found no significant difference versus placebo. Cochrane concluded evidence is 'equivocal at best.' Notable hepatotoxicity concerns exist, particularly in multi-ingredient products.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dgarcinia\u002Dcambogia\u0026condition\u003Dobesity'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            C

        

        

            
結論

            
            
Meta-analysis of 12 RCTs found small weight loss of 0.88 kg. However, the landmark JAMA trial (n=135) found no significant difference versus placebo. Cochrane concluded evidence is 'equivocal at best.' Notable hepatotoxicity concerns exist, particularly in multi-ingredient products.

            
            
        

    











    
    

        
        

            

  
Key Statistics





            


    

        
12

        
研究数

    

    

        
800

        
参加者数

    

    

        
            
            ↔
            
        
        
Mixed

    

    

        C

        
グレード

    




        


        
        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
一般的な使用量

                

                    
                    

                        
general:

                        
500-1,500 mg HCA/day (standardized to 50-60% HCA)

                    

                    
                    

                        
weightmanagement:

                        
1,500-2,800 mg HCA/day in divided doses

                    

                    
                

                
                

                    上限量： 2,800 mg HCA/day; hepatotoxicity cases reported (often in multi-ingredient products)
                

                
            

            

            

            
            

                推奨摂取タイミング： 30-60 minutes before meals
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
報告されている副作用

                    
    
                        
                        
  • 
                            ⚠
                            Headache
                        
    • 
                        
                        
  • 
                            ⚠
                            GI discomfort
                        
    • 
                        
                        
  • 
                            ⚠
                            Liver toxicity (reported in multi-ingredient products)
                        
    • 
                        
                        
  • 
                            ⚠
                            Nausea
                        
    • 
                        
                    

                

                

                
                

                    
既知の相互作用

                    
    
                        
                        
  • 
                            ●
                            Diabetes medications (may affect blood sugar)
                        
    • 
                        
                        
  • 
                            ●
                            Statins (potential liver concern)
                        
    • 
                        
                        
  • 
                            ●
                            SSRIs (theoretical serotonergic interaction)
                        
    • 
                        
                    

                

                

                
                

                    

                        耐容上限摂取量： 2,800 mg HCA/day; hepatotoxicity cases reported (often in multi-ingredient products)
                    

                

                
            

            

                サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Garcinia Cambogia help with Obesity?
            
        
        

            Based on 12 studies with 800 participants, there is limited but promising evidence that Garcinia Cambogia may support Obesity management. Our evidence grade is C (Some Evidence).
        

    

    
    

        
            How much Garcinia Cambogia should I take for Obesity?
            
        
        

            Studies have used various dosages. A commonly studied range is 500-1,500 mg HCA/day (standardized to 50-60% HCA). Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Garcinia Cambogia?
            
        
        

            Reported side effects may include Headache, GI discomfort, Liver toxicity (reported in multi-ingredient products), Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Garcinia Cambogia and Obesity?
            
        
        

            We rate the evidence as Grade C (Some Evidence). This rating is based on 12 peer-reviewed studies with 800 total participants. The overall direction of effect is mixed.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                
                

                
            

        

        

    


    
    












    

        FDAに関する免責事項:
        これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。